OR WAIT null SECS
October 14, 2021
This acquisition grants Bionano access to BioDiscovery’s clinical software solution for variant analysis.
The collaboration between Intellia and SparingVision will work to develop genomic medicines for ocular diseases.
The Pharmaceutical Technology and BioPharm International editors host industry experts, highlighting trends and new technologies.
Avid Bioservices is building a viral vector development and manufacturing facility near its existing biologics manufacturing facility in California.
Enzyvant’s Rethymic is the first FDA approved treatment for congenital athymia.
Element’s acquisition of Nanosyn is the latest in a series of moves made to strengthen the company’s North American presence.
Roche has submitted a marketing authorization application to EMA for Ronapreve (casirivimab/imdevimab) as a treatment for COVID-19.
EMA has halted the rolling review of CureVac's COVID-19 candidate, CVnCoV, due to the company withdrawing from the process.
MHRA has awarded an ‘Innovation Passport’ to CellResearch for its umbilical cord lining stem cell therapy, CorLiCyte.
October 13, 2021
Smiths Detection has confirmed that the Bioflash air sampler can detect Beta, Gamma, Kappa, Delta, and Delta plus variants.